{
  "doc_id": "9_acidbasedisorders__e5bcc9",
  "original_filename": "9_AcidBaseDisorders.pdf",
  "md_path": "data/parsed/9_AcidBaseDisorders/9_AcidBaseDisorders.md",
  "rmd_path": "data/parsed/9_AcidBaseDisorders/9_AcidBaseDisorders.rmd",
  "blocks": [
    {
      "type": "heading",
      "level": 1,
      "section": "NUTRITION SUPPORT CERTIFICATE",
      "line": 0
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Acid-Base Disorders",
      "line": 2
    },
    {
      "type": "image",
      "section": "Acid-Base Disorders",
      "line": 4,
      "content": "![img-0.jpeg](images/a1843a3ab3082a6b.png)"
    },
    {
      "type": "text",
      "section": "Acid-Base Disorders",
      "line": 6,
      "preview": "Planned by the American Society of Health-System Pharmacists (ASHP) in collaboration with the Americ"
    },
    {
      "type": "text",
      "section": "Acid-Base Disorders",
      "line": 7,
      "preview": "(c)2022 American Society of Health-System Pharmacists, Inc. All rights reserved."
    },
    {
      "type": "text",
      "section": "Acid-Base Disorders",
      "line": 9,
      "preview": "No part of this publication may be reproduced or transmitted in any form or by any means, electronic"
    },
    {
      "type": "text",
      "section": "Acid-Base Disorders",
      "line": 11,
      "preview": "--- page 1 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "NUTRITION SUPPORT COMPLICATIONS: ACID-BASE DISORDERS",
      "line": 13
    },
    {
      "type": "text",
      "section": "NUTRITION SUPPORT COMPLICATIONS: ACID-BASE DISORDERS",
      "line": 15,
      "preview": "Anne M. Tucker, Pharm.D., BCNSP"
    },
    {
      "type": "text",
      "section": "NUTRITION SUPPORT COMPLICATIONS: ACID-BASE DISORDERS",
      "line": 16,
      "preview": "University of Texas MD Anderson Cancer Center"
    },
    {
      "type": "text",
      "section": "NUTRITION SUPPORT COMPLICATIONS: ACID-BASE DISORDERS",
      "line": 18,
      "preview": "NUTRITION SUPPORT CERTIFICATE"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "RELEVANT FINANCIAL RELATIONSHIP DISCLOSURE",
      "line": 20
    },
    {
      "type": "text",
      "section": "RELEVANT FINANCIAL RELATIONSHIP DISCLOSURE",
      "line": 22,
      "preview": "The following persons in control of this activity's content have relevant financial relationships:"
    },
    {
      "type": "text",
      "section": "RELEVANT FINANCIAL RELATIONSHIP DISCLOSURE",
      "line": 24,
      "preview": "- Jay Mirtallo: Fresenius Kabi, consultant"
    },
    {
      "type": "text",
      "section": "RELEVANT FINANCIAL RELATIONSHIP DISCLOSURE",
      "line": 26,
      "preview": "All other persons in control of content do not have any relevant financial relationships with an ine"
    },
    {
      "type": "text",
      "section": "RELEVANT FINANCIAL RELATIONSHIP DISCLOSURE",
      "line": 28,
      "preview": "As defined by the Standards of Integrity and Independence definition of ineligible company. All rele"
    },
    {
      "type": "text",
      "section": "RELEVANT FINANCIAL RELATIONSHIP DISCLOSURE",
      "line": 30,
      "preview": "--- page 2 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "LEARNING OBJECTIVES",
      "line": 32
    },
    {
      "type": "text",
      "section": "LEARNING OBJECTIVES",
      "line": 34,
      "preview": "- Analyze patient information to determine type acid-base disorder."
    },
    {
      "type": "text",
      "section": "LEARNING OBJECTIVES",
      "line": 35,
      "preview": "- Describe common etiologies of acid-base disorders and their impact on the nutrition prescription."
    },
    {
      "type": "text",
      "section": "LEARNING OBJECTIVES",
      "line": 36,
      "preview": "- Design recommendations for the prevention and management of acid-base disorders."
    },
    {
      "type": "heading",
      "level": 2,
      "section": "KEY ABBREVIATIONS",
      "line": 39
    },
    {
      "type": "text",
      "section": "KEY ABBREVIATIONS",
      "line": 41,
      "preview": "- ABG:"
    },
    {
      "type": "text",
      "section": "KEY ABBREVIATIONS",
      "line": 42,
      "preview": "- AG:"
    },
    {
      "type": "text",
      "section": "KEY ABBREVIATIONS",
      "line": 43,
      "preview": "- BUN:"
    },
    {
      "type": "text",
      "section": "KEY ABBREVIATIONS",
      "line": 44,
      "preview": "- Ca:"
    },
    {
      "type": "text",
      "section": "KEY ABBREVIATIONS",
      "line": 45,
      "preview": "- $\\mathrm{Cl}:$"
    },
    {
      "type": "text",
      "section": "KEY ABBREVIATIONS",
      "line": 46,
      "preview": "- $\\mathrm{CO}_{2}$ :"
    },
    {
      "type": "text",
      "section": "KEY ABBREVIATIONS",
      "line": 47,
      "preview": "- COPD:"
    },
    {
      "type": "text",
      "section": "KEY ABBREVIATIONS",
      "line": 48,
      "preview": "- ECF:"
    },
    {
      "type": "text",
      "section": "KEY ABBREVIATIONS",
      "line": 49,
      "preview": "- $\\mathrm{H}^{+}$:"
    },
    {
      "type": "text",
      "section": "KEY ABBREVIATIONS",
      "line": 50,
      "preview": "- $\\mathrm{HCO}_{3}$ : arterial blood gas"
    },
    {
      "type": "text",
      "section": "KEY ABBREVIATIONS",
      "line": 51,
      "preview": "anion gap"
    },
    {
      "type": "text",
      "section": "KEY ABBREVIATIONS",
      "line": 52,
      "preview": "blood urea nitrogen"
    },
    {
      "type": "text",
      "section": "KEY ABBREVIATIONS",
      "line": 53,
      "preview": "calcium"
    },
    {
      "type": "text",
      "section": "KEY ABBREVIATIONS",
      "line": 54,
      "preview": "chloride"
    },
    {
      "type": "text",
      "section": "KEY ABBREVIATIONS",
      "line": 55,
      "preview": "carbon dioxide"
    },
    {
      "type": "text",
      "section": "KEY ABBREVIATIONS",
      "line": 56,
      "preview": "chronic obstructive pulmonary disease"
    },
    {
      "type": "text",
      "section": "KEY ABBREVIATIONS",
      "line": 57,
      "preview": "extracellular fluid"
    },
    {
      "type": "text",
      "section": "KEY ABBREVIATIONS",
      "line": 58,
      "preview": "hydrogen ion"
    },
    {
      "type": "text",
      "section": "KEY ABBREVIATIONS",
      "line": 59,
      "preview": "bicarbonate"
    },
    {
      "type": "text",
      "section": "KEY ABBREVIATIONS",
      "line": 61,
      "preview": "--- page 3 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "KEY ABBREVIATIONS, CONT.",
      "line": 63
    },
    {
      "type": "text",
      "section": "KEY ABBREVIATIONS, CONT.",
      "line": 65,
      "preview": "- ICF:"
    },
    {
      "type": "text",
      "section": "KEY ABBREVIATIONS, CONT.",
      "line": 66,
      "preview": "- K:"
    },
    {
      "type": "text",
      "section": "KEY ABBREVIATIONS, CONT.",
      "line": 67,
      "preview": "- Mg :"
    },
    {
      "type": "text",
      "section": "KEY ABBREVIATIONS, CONT.",
      "line": 68,
      "preview": "- Na :"
    },
    {
      "type": "text",
      "section": "KEY ABBREVIATIONS, CONT.",
      "line": 69,
      "preview": "- NG:"
    },
    {
      "type": "text",
      "section": "KEY ABBREVIATIONS, CONT.",
      "line": 70,
      "preview": "- P:"
    },
    {
      "type": "text",
      "section": "KEY ABBREVIATIONS, CONT.",
      "line": 71,
      "preview": "- $\\mathrm{pCO}_{2}$ :"
    },
    {
      "type": "text",
      "section": "KEY ABBREVIATIONS, CONT.",
      "line": 72,
      "preview": "- PN:"
    },
    {
      "type": "text",
      "section": "KEY ABBREVIATIONS, CONT.",
      "line": 73,
      "preview": "- $\\mathrm{pO}_{2}$ :"
    },
    {
      "type": "text",
      "section": "KEY ABBREVIATIONS, CONT.",
      "line": 74,
      "preview": "- uCl :"
    },
    {
      "type": "text",
      "section": "KEY ABBREVIATIONS, CONT.",
      "line": 75,
      "preview": "intracellular fluid"
    },
    {
      "type": "text",
      "section": "KEY ABBREVIATIONS, CONT.",
      "line": 76,
      "preview": "potassium"
    },
    {
      "type": "text",
      "section": "KEY ABBREVIATIONS, CONT.",
      "line": 77,
      "preview": "magnesium"
    },
    {
      "type": "text",
      "section": "KEY ABBREVIATIONS, CONT.",
      "line": 78,
      "preview": "sodium"
    },
    {
      "type": "text",
      "section": "KEY ABBREVIATIONS, CONT.",
      "line": 79,
      "preview": "nasogastric"
    },
    {
      "type": "text",
      "section": "KEY ABBREVIATIONS, CONT.",
      "line": 80,
      "preview": "phosphorus"
    },
    {
      "type": "text",
      "section": "KEY ABBREVIATIONS, CONT.",
      "line": 81,
      "preview": "partial pressure of carbon dioxide"
    },
    {
      "type": "text",
      "section": "KEY ABBREVIATIONS, CONT.",
      "line": 82,
      "preview": "parenteral nutrition"
    },
    {
      "type": "text",
      "section": "KEY ABBREVIATIONS, CONT.",
      "line": 83,
      "preview": "partial pressure of oxygen"
    },
    {
      "type": "text",
      "section": "KEY ABBREVIATIONS, CONT.",
      "line": 84,
      "preview": "urine chloride"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "SELF-ASSESSMENT \\#1",
      "line": 87
    },
    {
      "type": "text",
      "section": "SELF-ASSESSMENT \\#1",
      "line": 89,
      "preview": "- RK is a 55 year old male home PN patient who presents to the Emergency Department for hypovolemia "
    },
    {
      "type": "text",
      "section": "SELF-ASSESSMENT \\#1",
      "line": 90,
      "preview": "- Laboratory values:"
    },
    {
      "type": "table",
      "section": "SELF-ASSESSMENT \\#1",
      "line": 92,
      "preview": "| Na: $139 \\mathrm{mEq} / \\mathrm{L}$ | Glucose: $122 \\mathrm{mg} / \\mathrm{dL}$ |"
    },
    {
      "type": "table",
      "section": "SELF-ASSESSMENT \\#1",
      "line": 93,
      "preview": "| :--: | :--: |"
    },
    {
      "type": "table",
      "section": "SELF-ASSESSMENT \\#1",
      "line": 94,
      "preview": "| K: $3.7 \\mathrm{mEq} / \\mathrm{L}$ | ABG: |"
    },
    {
      "type": "table",
      "section": "SELF-ASSESSMENT \\#1",
      "line": 95,
      "preview": "| Cl: $98 \\mathrm{mEq} / \\mathrm{L}$ | $\\mathrm{pH}: 7.46$ |"
    },
    {
      "type": "table",
      "section": "SELF-ASSESSMENT \\#1",
      "line": 96,
      "preview": "| $\\mathrm{CO}_{2}: 34 \\mathrm{mEq} / \\mathrm{L}$ | $\\mathrm{pCO}_{2}: 46 \\mathrm{mmHg}$ |"
    },
    {
      "type": "table",
      "section": "SELF-ASSESSMENT \\#1",
      "line": 97,
      "preview": "| BUN: $21 \\mathrm{mg} / \\mathrm{dL}$ | $\\mathrm{PO}_{2}: 92 \\mathrm{mmHg}$ |"
    },
    {
      "type": "table",
      "section": "SELF-ASSESSMENT \\#1",
      "line": 98,
      "preview": "| Cr: $0.9 \\mathrm{mg} / \\mathrm{dL}$ | $\\mathrm{HCO}_{3}{ }^{-}: 34 \\mathrm{mmol} / \\mathrm{L}$ |"
    },
    {
      "type": "text",
      "section": "SELF-ASSESSMENT \\#1",
      "line": 100,
      "preview": "--- page 4 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "SELF-ASSESSMENT \\#1, CONT.",
      "line": 102
    },
    {
      "type": "text",
      "section": "SELF-ASSESSMENT \\#1, CONT.",
      "line": 104,
      "preview": "Upon admission to the hospital and continuation of PN, what change should be made based on RK's ABG?"
    },
    {
      "type": "text",
      "section": "SELF-ASSESSMENT \\#1, CONT.",
      "line": 105,
      "preview": "A. Initiate mechanical ventilation"
    },
    {
      "type": "text",
      "section": "SELF-ASSESSMENT \\#1, CONT.",
      "line": 106,
      "preview": "B. Increase chloride salts in the PN"
    },
    {
      "type": "text",
      "section": "SELF-ASSESSMENT \\#1, CONT.",
      "line": 107,
      "preview": "C. Increase acetate salts in the PN"
    },
    {
      "type": "text",
      "section": "SELF-ASSESSMENT \\#1, CONT.",
      "line": 108,
      "preview": "D. Decrease calorie content of PN"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "GENERAL PRINCIPLES - PH",
      "line": 110
    },
    {
      "type": "text",
      "section": "GENERAL PRINCIPLES - PH",
      "line": 112,
      "preview": "- The degree of acidity in the blood"
    },
    {
      "type": "text",
      "section": "GENERAL PRINCIPLES - PH",
      "line": 113,
      "preview": "- Acidity of the blood is based on the hydrogen ion $(\\mathrm{H}+)$ concentration"
    },
    {
      "type": "text",
      "section": "GENERAL PRINCIPLES - PH",
      "line": 114,
      "preview": "- pH is maintained at $7.40(7.35$ to 7.45$)$"
    },
    {
      "type": "text",
      "section": "GENERAL PRINCIPLES - PH",
      "line": 115,
      "preview": "- Associated disorders"
    },
    {
      "type": "text",
      "section": "GENERAL PRINCIPLES - PH",
      "line": 116,
      "preview": "- Acidosis: lead to $\\mathrm{pH}<7.35$"
    },
    {
      "type": "text",
      "section": "GENERAL PRINCIPLES - PH",
      "line": 117,
      "preview": "- Alkalosis: lead to $\\mathrm{pH}>7.45$"
    },
    {
      "type": "text",
      "section": "GENERAL PRINCIPLES - PH",
      "line": 119,
      "preview": "--- page 5 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "GENERAL PRINCIPLES - H+",
      "line": 121
    },
    {
      "type": "text",
      "section": "GENERAL PRINCIPLES - H+",
      "line": 123,
      "preview": "- Regulation via 3 mechanisms"
    },
    {
      "type": "text",
      "section": "GENERAL PRINCIPLES - H+",
      "line": 124,
      "preview": "- Chemical buffering by extracellular and intracellular mechanisms"
    },
    {
      "type": "text",
      "section": "GENERAL PRINCIPLES - H+",
      "line": 125,
      "preview": "- Control of $\\mathrm{pCO}_{2}$ in the blood by the lungs via alterations in the rate and depth of v"
    },
    {
      "type": "text",
      "section": "GENERAL PRINCIPLES - H+",
      "line": 126,
      "preview": "- Control of the serum $\\mathrm{HCO}_{3}{ }^{-}$concentration by alterations in renal $\\mathrm{H}+$ "
    },
    {
      "type": "text",
      "section": "GENERAL PRINCIPLES - H+",
      "line": 128,
      "preview": "Ayers P et al. Nutr Clin Pract. 2014; 30:14-20."
    },
    {
      "type": "text",
      "section": "GENERAL PRINCIPLES - H+",
      "line": 129,
      "preview": "Adrogue, HJ et al. Kidney Int. 2009; 76:1239-47."
    },
    {
      "type": "text",
      "section": "GENERAL PRINCIPLES - H+",
      "line": 130,
      "preview": "Al-Jaghbeer M, Kellum JA. Nephrol Dial Transplant. 2015; 30:1104-11."
    },
    {
      "type": "heading",
      "level": 2,
      "section": "GENERAL PRINCIPLES - BUFFERS",
      "line": 132
    },
    {
      "type": "text",
      "section": "GENERAL PRINCIPLES - BUFFERS",
      "line": 134,
      "preview": "- Most abundant ECF buffer"
    },
    {
      "type": "text",
      "section": "GENERAL PRINCIPLES - BUFFERS",
      "line": 135,
      "preview": "- Carbonic acid/bicarbonate system"
    },
    {
      "type": "text",
      "section": "GENERAL PRINCIPLES - BUFFERS",
      "line": 137,
      "preview": "$$"
    },
    {
      "type": "text",
      "section": "GENERAL PRINCIPLES - BUFFERS",
      "line": 138,
      "preview": "\\begin{aligned}"
    },
    {
      "type": "text",
      "section": "GENERAL PRINCIPLES - BUFFERS",
      "line": 139,
      "preview": "& \\mathrm{H}_{2} \\mathrm{O}+\\mathrm{CO}_{2} \\longleftrightarrow \\mathrm{H}_{2} \\mathrm{CO}_{3} \\long"
    },
    {
      "type": "text",
      "section": "GENERAL PRINCIPLES - BUFFERS",
      "line": 140,
      "preview": "& \\text {Carbonic acid Bicarbonate }"
    },
    {
      "type": "text",
      "section": "GENERAL PRINCIPLES - BUFFERS",
      "line": 141,
      "preview": "\\end{aligned}"
    },
    {
      "type": "text",
      "section": "GENERAL PRINCIPLES - BUFFERS",
      "line": 142,
      "preview": "$$"
    },
    {
      "type": "text",
      "section": "GENERAL PRINCIPLES - BUFFERS",
      "line": 144,
      "preview": "- $\\sim 15,000 \\mathrm{mmol} \\mathrm{CO}_{2}$ produced daily from fat and carbohydrate metabolism"
    },
    {
      "type": "text",
      "section": "GENERAL PRINCIPLES - BUFFERS",
      "line": 145,
      "preview": "- Lungs eliminate to prevent buildup of $\\mathrm{CO}_{2}$"
    },
    {
      "type": "text",
      "section": "GENERAL PRINCIPLES - BUFFERS",
      "line": 146,
      "preview": "- Other buffers: plasma proteins, hemoglobin, phosphates"
    },
    {
      "type": "text",
      "section": "GENERAL PRINCIPLES - BUFFERS",
      "line": 148,
      "preview": "--- page 6 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "ACID-BASE GENERAL PRINCIPLES",
      "line": 150
    },
    {
      "type": "text",
      "section": "ACID-BASE GENERAL PRINCIPLES",
      "line": 152,
      "preview": "- Described by the Henderson-Hasselbalch equation"
    },
    {
      "type": "text",
      "section": "ACID-BASE GENERAL PRINCIPLES",
      "line": 153,
      "preview": "- $\\mathrm{pH}=6.1+\\log \\left(\\left[\\mathrm{HCO}_{3}^{-}\\right] /\\left(0.03 \\times \\mathrm{pCO}_{2}\\"
    },
    {
      "type": "text",
      "section": "ACID-BASE GENERAL PRINCIPLES",
      "line": 154,
      "preview": "- $\\mathrm{HCO}_{3}^{-}$"
    },
    {
      "type": "text",
      "section": "ACID-BASE GENERAL PRINCIPLES",
      "line": 155,
      "preview": "- Base component"
    },
    {
      "type": "text",
      "section": "ACID-BASE GENERAL PRINCIPLES",
      "line": 156,
      "preview": "- Calculated from arterial pH and $\\mathrm{pCO}_{2}$"
    },
    {
      "type": "text",
      "section": "ACID-BASE GENERAL PRINCIPLES",
      "line": 157,
      "preview": "$-\\mathrm{pCO}_{2}$"
    },
    {
      "type": "text",
      "section": "ACID-BASE GENERAL PRINCIPLES",
      "line": 158,
      "preview": "- Acid component"
    },
    {
      "type": "text",
      "section": "ACID-BASE GENERAL PRINCIPLES",
      "line": 159,
      "preview": "- Measured in serum"
    },
    {
      "type": "text",
      "section": "ACID-BASE GENERAL PRINCIPLES",
      "line": 161,
      "preview": "Ayers P et al. JPEN J Parent Enteral Nutr. 2012; 36:18-23."
    },
    {
      "type": "heading",
      "level": 2,
      "section": "ARTERIAL BLOOD GAS (ABG)",
      "line": 163
    },
    {
      "type": "text",
      "section": "ARTERIAL BLOOD GAS (ABG)",
      "line": 165,
      "preview": "- Laboratory analysis that reflects the ability of the lungs to oxygenate blood"
    },
    {
      "type": "text",
      "section": "ARTERIAL BLOOD GAS (ABG)",
      "line": 166,
      "preview": "- $\\mathrm{pH} / \\mathrm{pCO}_{2} / \\mathrm{pO}_{2} / \\mathrm{HCO}_{3}^{-}$"
    },
    {
      "type": "table",
      "section": "ARTERIAL BLOOD GAS (ABG)",
      "line": 168,
      "preview": "|  | Normal ABG values |"
    },
    {
      "type": "table",
      "section": "ARTERIAL BLOOD GAS (ABG)",
      "line": 169,
      "preview": "| :-- | :--: |"
    },
    {
      "type": "table",
      "section": "ARTERIAL BLOOD GAS (ABG)",
      "line": 170,
      "preview": "| pH | $7.40(7.35-7.45)$ |"
    },
    {
      "type": "table",
      "section": "ARTERIAL BLOOD GAS (ABG)",
      "line": 171,
      "preview": "| $\\mathrm{pCO}_{2}(\\mathrm{~mm} \\mathrm{Hg})$ | $40(35-45)$ |"
    },
    {
      "type": "table",
      "section": "ARTERIAL BLOOD GAS (ABG)",
      "line": 172,
      "preview": "| $\\mathrm{pO}_{2}(\\mathrm{~mm} \\mathrm{Hg})$ | $80-100$ |"
    },
    {
      "type": "table",
      "section": "ARTERIAL BLOOD GAS (ABG)",
      "line": 173,
      "preview": "| $\\mathrm{HCO}_{3}{ }^{-}(\\mathrm{mEq} / \\mathrm{L})$ | $24(22-26)$ |"
    },
    {
      "type": "text",
      "section": "ARTERIAL BLOOD GAS (ABG)",
      "line": 175,
      "preview": "--- page 7 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "ACID-BASE DISORDERS",
      "line": 177
    },
    {
      "type": "text",
      "section": "ACID-BASE DISORDERS",
      "line": 179,
      "preview": "- Metabolic acidosis"
    },
    {
      "type": "text",
      "section": "ACID-BASE DISORDERS",
      "line": 180,
      "preview": "- Metabolic alkalosis"
    },
    {
      "type": "text",
      "section": "ACID-BASE DISORDERS",
      "line": 181,
      "preview": "- Respiratory acidosis"
    },
    {
      "type": "text",
      "section": "ACID-BASE DISORDERS",
      "line": 182,
      "preview": "- Respiratory alkalosis"
    },
    {
      "type": "text",
      "section": "ACID-BASE DISORDERS",
      "line": 183,
      "preview": "- Mixed disorders"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "METABOLIC DISORDERS",
      "line": 186
    },
    {
      "type": "text",
      "section": "METABOLIC DISORDERS",
      "line": 188,
      "preview": "- Result from disturbances in plasma $\\mathrm{HCO}_{3}{ }^{-}$"
    },
    {
      "type": "text",
      "section": "METABOLIC DISORDERS",
      "line": 189,
      "preview": "- Regulated by the kidneys"
    },
    {
      "type": "text",
      "section": "METABOLIC DISORDERS",
      "line": 190,
      "preview": "- $\\mathrm{HCO}_{3}{ }^{-}$is the basic component in the carbonic acid/bicarbonate buffer system"
    },
    {
      "type": "text",
      "section": "METABOLIC DISORDERS",
      "line": 191,
      "preview": "- Normal value $24 \\mathrm{mmol} / \\mathrm{L}$ (range $22-26 \\mathrm{mmol} / \\mathrm{L}$ )"
    },
    {
      "type": "text",
      "section": "METABOLIC DISORDERS",
      "line": 192,
      "preview": "- Metabolic acidosis $\\mathrm{HCO}_{3}{ }^{-}$is $<24$"
    },
    {
      "type": "text",
      "section": "METABOLIC DISORDERS",
      "line": 193,
      "preview": "- Metabolic alkalosis $\\mathrm{HCO}_{3}{ }^{-}$is $>24$"
    },
    {
      "type": "text",
      "section": "METABOLIC DISORDERS",
      "line": 195,
      "preview": "Ayers P et al. Nutr Clin Pract. 2014; 30:14-20."
    },
    {
      "type": "text",
      "section": "METABOLIC DISORDERS",
      "line": 196,
      "preview": "Adrogue HJ et al. Kidney Int. 2009; 76:1239-47."
    },
    {
      "type": "text",
      "section": "METABOLIC DISORDERS",
      "line": 197,
      "preview": "Al-Jaghbeer M, Kellum JA. Nephrol Dial Transplant. 2015; 30:1104-11."
    },
    {
      "type": "text",
      "section": "METABOLIC DISORDERS",
      "line": 199,
      "preview": "--- page 8 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "RESPIRATORY DISORDERS",
      "line": 201
    },
    {
      "type": "text",
      "section": "RESPIRATORY DISORDERS",
      "line": 203,
      "preview": "- Alterations in alveolar ventilation leading to changes in $\\mathrm{PCO}_{2}$"
    },
    {
      "type": "text",
      "section": "RESPIRATORY DISORDERS",
      "line": 204,
      "preview": "- $\\mathrm{pCO}_{2}$ is the acidic component in the carbonic acid/bicarbonate buffer system"
    },
    {
      "type": "text",
      "section": "RESPIRATORY DISORDERS",
      "line": 205,
      "preview": "- Normal value 40 mmHg (range $35-45 \\mathrm{mmHg}$ )"
    },
    {
      "type": "text",
      "section": "RESPIRATORY DISORDERS",
      "line": 206,
      "preview": "- Respiratory acidosis $\\mathrm{pCO}_{2}$ is $>40$"
    },
    {
      "type": "text",
      "section": "RESPIRATORY DISORDERS",
      "line": 207,
      "preview": "- Respiratory alkalosis $\\mathrm{pCO}_{2}$ is $<40$"
    },
    {
      "type": "text",
      "section": "RESPIRATORY DISORDERS",
      "line": 209,
      "preview": "Ayers P et al. Nutr Clin Pract. 2014; 30:14-20."
    },
    {
      "type": "text",
      "section": "RESPIRATORY DISORDERS",
      "line": 210,
      "preview": "Adrogue HJ et al. Kidney Int. 2009; 76:1239-47."
    },
    {
      "type": "text",
      "section": "RESPIRATORY DISORDERS",
      "line": 211,
      "preview": "Al-Jaghbeer M, Kellum JA. Nephrol Dial Transplant. 2015; 30:1104-11."
    },
    {
      "type": "heading",
      "level": 2,
      "section": "COMPENSATION",
      "line": 213
    },
    {
      "type": "text",
      "section": "COMPENSATION",
      "line": 215,
      "preview": "- Metabolic disorders"
    },
    {
      "type": "text",
      "section": "COMPENSATION",
      "line": 216,
      "preview": "- Lungs regulate $\\mathrm{pCO}_{2}$ by altering the rate and depth of ventilation"
    },
    {
      "type": "text",
      "section": "COMPENSATION",
      "line": 217,
      "preview": "- Excretion of $\\mathrm{CO}_{2}$ generated by diet and cellular metabolism"
    },
    {
      "type": "text",
      "section": "COMPENSATION",
      "line": 218,
      "preview": "- Compensation starts within minutes"
    },
    {
      "type": "text",
      "section": "COMPENSATION",
      "line": 219,
      "preview": "- Respiratory disorders"
    },
    {
      "type": "text",
      "section": "COMPENSATION",
      "line": 220,
      "preview": "- Kidneys regulate $\\mathrm{HCO}_{3}{ }^{-}$via alterations in renal $\\mathrm{HCO}_{3}{ }^{-}$excret"
    },
    {
      "type": "text",
      "section": "COMPENSATION",
      "line": 221,
      "preview": "- Compensation fully activated in 2 - 3 days"
    },
    {
      "type": "text",
      "section": "COMPENSATION",
      "line": 223,
      "preview": "Ayers P et al. Nutr Clin Pract. 2014; 30:14-20."
    },
    {
      "type": "text",
      "section": "COMPENSATION",
      "line": 224,
      "preview": "Adrogue HJ et al. Kidney Int. 2009; 76:1239-47."
    },
    {
      "type": "text",
      "section": "COMPENSATION",
      "line": 225,
      "preview": "Al-Jaghbeer M, Kellum JA. Nephrol Dial Transplant. 2015; 30:1104-11."
    },
    {
      "type": "text",
      "section": "COMPENSATION",
      "line": 227,
      "preview": "--- page 9 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "PUTTING IT TOGETHER",
      "line": 229
    },
    {
      "type": "table",
      "section": "PUTTING IT TOGETHER",
      "line": 231,
      "preview": "| Acid-Base <br> Disorder | pH | Primary Disturbance | Compensatory <br> Response |"
    },
    {
      "type": "table",
      "section": "PUTTING IT TOGETHER",
      "line": 232,
      "preview": "| :--: | :--: | :--: | :--: |"
    },
    {
      "type": "table",
      "section": "PUTTING IT TOGETHER",
      "line": 233,
      "preview": "| Respiratory |  |  |  |"
    },
    {
      "type": "table",
      "section": "PUTTING IT TOGETHER",
      "line": 234,
      "preview": "| Acidosis | $\\downarrow$ | $\\uparrow \\mathrm{PCO}_{2}$ | $\\uparrow \\mathrm{HCO}_{3}{ }^{-}$ |"
    },
    {
      "type": "table",
      "section": "PUTTING IT TOGETHER",
      "line": 235,
      "preview": "| Alkalosis | $\\uparrow$ | $\\downarrow \\mathrm{PCO}_{2}$ | $\\downarrow \\mathrm{HCO}_{3}{ }^{-}$ |"
    },
    {
      "type": "table",
      "section": "PUTTING IT TOGETHER",
      "line": 236,
      "preview": "| Metabolic |  |  |  |"
    },
    {
      "type": "table",
      "section": "PUTTING IT TOGETHER",
      "line": 237,
      "preview": "| Acidosis | $\\downarrow$ | $\\downarrow \\mathrm{HCO}_{3}{ }^{-}$ | $\\downarrow \\mathrm{PCO}_{2}$ |"
    },
    {
      "type": "table",
      "section": "PUTTING IT TOGETHER",
      "line": 238,
      "preview": "| Alkalosis | $\\uparrow$ | $\\uparrow \\mathrm{HCO}_{3}{ }^{-}$ | $\\uparrow \\mathrm{PCO}_{2}$ |"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "COMPENSATION FORMULAS",
      "line": 240
    },
    {
      "type": "table",
      "section": "COMPENSATION FORMULAS",
      "line": 242,
      "preview": "| Disorder | Compensation Formula |"
    },
    {
      "type": "table",
      "section": "COMPENSATION FORMULAS",
      "line": 243,
      "preview": "| :--: | :--: |"
    },
    {
      "type": "table",
      "section": "COMPENSATION FORMULAS",
      "line": 244,
      "preview": "| Metabolic acidosis | Expected $\\mathrm{pCO}_{2}=40-\\left[1.2 \\times\\left(24\\right.\\right.$ - measu"
    },
    {
      "type": "table",
      "section": "COMPENSATION FORMULAS",
      "line": 245,
      "preview": "| Metabolic alkalosis | Expected $\\mathrm{pCO}_{2}=40+\\left[0.7 \\times\\left(\\right.\\right.$ measured"
    },
    {
      "type": "table",
      "section": "COMPENSATION FORMULAS",
      "line": 246,
      "preview": "| Acute respiratory acidosis | Expected decrease in $\\mathrm{pH}=0.08 \\times\\left(\\right.$ measured "
    },
    {
      "type": "table",
      "section": "COMPENSATION FORMULAS",
      "line": 247,
      "preview": "| Chronic respiratory acidosis | Expected decrease in $\\mathrm{pH}=0.03 \\times\\left(\\right.$ measure"
    },
    {
      "type": "table",
      "section": "COMPENSATION FORMULAS",
      "line": 248,
      "preview": "| Acute respiratory alkalosis | Expected increase in $\\mathrm{pH}=0.08 \\times\\left(40\\right.$ - meas"
    },
    {
      "type": "table",
      "section": "COMPENSATION FORMULAS",
      "line": 249,
      "preview": "| Chronic respiratory alkalosis | Expected increase in $\\mathrm{pH}=0.03 \\times\\left(40\\right.$ - me"
    },
    {
      "type": "table",
      "section": "COMPENSATION FORMULAS",
      "line": 250,
      "preview": "| *Expected values should be within 10\\% of actual to determine simple disorders |  |"
    },
    {
      "type": "text",
      "section": "COMPENSATION FORMULAS",
      "line": 252,
      "preview": "DiPiro J et al., ed. New York: McGraw-Hill Education; 2014."
    },
    {
      "type": "text",
      "section": "COMPENSATION FORMULAS",
      "line": 254,
      "preview": "--- page 10 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "ADDITIONAL FORMULAS",
      "line": 256
    },
    {
      "type": "table",
      "section": "ADDITIONAL FORMULAS",
      "line": 258,
      "preview": "| Disorder | Compensatory Response |"
    },
    {
      "type": "table",
      "section": "ADDITIONAL FORMULAS",
      "line": 259,
      "preview": "| :-- | :-- |"
    },
    {
      "type": "table",
      "section": "ADDITIONAL FORMULAS",
      "line": 260,
      "preview": "| Acute Respiratory Acidosis | $1 \\mathrm{mEq} / \\mathrm{L}$ increase in $\\mathrm{HCO}_{3}{ }^{-}$fo"
    },
    {
      "type": "table",
      "section": "ADDITIONAL FORMULAS",
      "line": 261,
      "preview": "| Chronic Respiratory Acidosis | $3 \\mathrm{mEq} / \\mathrm{L}$ increase in $\\mathrm{HCO}_{3}{ }^{-}$"
    },
    {
      "type": "table",
      "section": "ADDITIONAL FORMULAS",
      "line": 262,
      "preview": "| Acute Respiratory Alkalosis | $2 \\mathrm{mEq} / \\mathrm{L}$ decrease in $\\mathrm{HCO}_{3}{ }^{-}$f"
    },
    {
      "type": "table",
      "section": "ADDITIONAL FORMULAS",
      "line": 263,
      "preview": "| Chronic Respiratory Alkalosis | $4 \\mathrm{mEq} / \\mathrm{L}$ decrease in $\\mathrm{HCO}_{3}{ }^{-}"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "MIXED DISORDER",
      "line": 265
    },
    {
      "type": "text",
      "section": "MIXED DISORDER",
      "line": 267,
      "preview": "- When two or more primary acid-base disorders occur simultaneously"
    },
    {
      "type": "text",
      "section": "MIXED DISORDER",
      "line": 268,
      "preview": "- Suspect if blood gas values are inappropriate for compensation"
    },
    {
      "type": "text",
      "section": "MIXED DISORDER",
      "line": 269,
      "preview": "- Examples:"
    },
    {
      "type": "text",
      "section": "MIXED DISORDER",
      "line": 270,
      "preview": "- Patient with sepsis and diabetic ketoacidosis"
    },
    {
      "type": "text",
      "section": "MIXED DISORDER",
      "line": 271,
      "preview": "- Patient with COPD and volume depletion secondary to loop diuretics"
    },
    {
      "type": "text",
      "section": "MIXED DISORDER",
      "line": 273,
      "preview": "--- page 11 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "SELF-ASSESSMENT \\#2",
      "line": 275
    },
    {
      "type": "text",
      "section": "SELF-ASSESSMENT \\#2",
      "line": 277,
      "preview": "A patient presents with a metabolic acidosis due to septic shock. Which ABG pattern fits this disord"
    },
    {
      "type": "text",
      "section": "SELF-ASSESSMENT \\#2",
      "line": 278,
      "preview": "A. Decreased pH , decreased $\\mathrm{HCO}_{3}^{-}$"
    },
    {
      "type": "text",
      "section": "SELF-ASSESSMENT \\#2",
      "line": 279,
      "preview": "B. Decreased pH , increased $\\mathrm{PCO}_{2}$"
    },
    {
      "type": "text",
      "section": "SELF-ASSESSMENT \\#2",
      "line": 280,
      "preview": "C. Increased pH , increased $\\mathrm{HCO}_{3}^{-}$"
    },
    {
      "type": "text",
      "section": "SELF-ASSESSMENT \\#2",
      "line": 281,
      "preview": "D. Increased pH , decreased $\\mathrm{PCO}_{2}$"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "METABOLIC ACIDOSIS",
      "line": 283
    },
    {
      "type": "text",
      "section": "METABOLIC ACIDOSIS",
      "line": 285,
      "preview": "- Decreased pH ( $<7.35$ ) due to decreased plasma $\\mathrm{HCO}_{3}{ }^{-}(<24 \\mathrm{mEq} / \\math"
    },
    {
      "type": "text",
      "section": "METABOLIC ACIDOSIS",
      "line": 286,
      "preview": "- Loss of bicarbonate-rich fluids"
    },
    {
      "type": "text",
      "section": "METABOLIC ACIDOSIS",
      "line": 287,
      "preview": "- Excessive administration of non-alkali based fluids"
    },
    {
      "type": "text",
      "section": "METABOLIC ACIDOSIS",
      "line": 288,
      "preview": "- Consumption or accumulation of acids $\\left(\\mathrm{H}_{+}\\right)$"
    },
    {
      "type": "text",
      "section": "METABOLIC ACIDOSIS",
      "line": 289,
      "preview": "- Pulmonary compensation"
    },
    {
      "type": "text",
      "section": "METABOLIC ACIDOSIS",
      "line": 290,
      "preview": "- Increase respiratory rate"
    },
    {
      "type": "text",
      "section": "METABOLIC ACIDOSIS",
      "line": 291,
      "preview": "- Decrease $\\mathrm{pCO}_{2}$"
    },
    {
      "type": "text",
      "section": "METABOLIC ACIDOSIS",
      "line": 292,
      "preview": "- Classified as normal or elevated anion gap"
    },
    {
      "type": "text",
      "section": "METABOLIC ACIDOSIS",
      "line": 294,
      "preview": "--- page 12 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "ANION GAP (AG)",
      "line": 296
    },
    {
      "type": "text",
      "section": "ANION GAP (AG)",
      "line": 298,
      "preview": "- Estimates the difference between measured and unmeasured major ECF cations and anions"
    },
    {
      "type": "text",
      "section": "ANION GAP (AG)",
      "line": 299,
      "preview": "- $\\mathrm{AG}=\\mathrm{Na}+-\\left(\\mathrm{Cl}^{-}+\\mathrm{HCO}_{3}^{-}\\right)$"
    },
    {
      "type": "text",
      "section": "ANION GAP (AG)",
      "line": 300,
      "preview": "- Normal AG $=3-11 \\mathrm{mEq} / \\mathrm{L}$"
    },
    {
      "type": "text",
      "section": "ANION GAP (AG)",
      "line": 301,
      "preview": "- $\\mathrm{AG}>17-20 \\mathrm{mEq} / \\mathrm{L}$ indicates accumulation of unmeasured anions"
    },
    {
      "type": "text",
      "section": "ANION GAP (AG)",
      "line": 302,
      "preview": "- $\\mathrm{AG}>20-25 \\mathrm{mEq} / \\mathrm{L}$ indicates significant organic acidosis"
    },
    {
      "type": "text",
      "section": "ANION GAP (AG)",
      "line": 303,
      "preview": "- 1:1 ratio between anions in blood"
    },
    {
      "type": "text",
      "section": "ANION GAP (AG)",
      "line": 304,
      "preview": "- Normal AG: Every $1 \\mathrm{mEq} / \\mathrm{L} \\uparrow$ in $\\mathrm{Cl}^{-}$should result in $1 \\m"
    },
    {
      "type": "text",
      "section": "ANION GAP (AG)",
      "line": 305,
      "preview": "- Elevated AG: Every 1-point $\\uparrow$ in AG should result in $1 \\mathrm{mEq} / \\mathrm{L} \\downarr"
    },
    {
      "type": "text",
      "section": "ANION GAP (AG)",
      "line": 307,
      "preview": "Ayers P et al. Nutr Clin Pract. 2014; 30:14-20."
    },
    {
      "type": "text",
      "section": "ANION GAP (AG)",
      "line": 309,
      "preview": "Etiology: Normal-Anion Gap Metabolic Acidosis"
    },
    {
      "type": "table",
      "section": "ANION GAP (AG)",
      "line": 311,
      "preview": "| $\\mathbf{U}$ | Ureteroenterostomy (urinary diversion) |"
    },
    {
      "type": "table",
      "section": "ANION GAP (AG)",
      "line": 312,
      "preview": "| :-- | :-- |"
    },
    {
      "type": "table",
      "section": "ANION GAP (AG)",
      "line": 313,
      "preview": "| $\\mathbf{S}$ | Small bowel (pancreatic/biliary) fistula |"
    },
    {
      "type": "table",
      "section": "ANION GAP (AG)",
      "line": 314,
      "preview": "| $\\mathbf{E}$ | Excessive chloride salts |"
    },
    {
      "type": "table",
      "section": "ANION GAP (AG)",
      "line": 315,
      "preview": "| $\\mathbf{D}$ | Diarrhea |"
    },
    {
      "type": "table",
      "section": "ANION GAP (AG)",
      "line": 316,
      "preview": "| $\\mathbf{C}$ | Carbonic anhydrase inhibitors (acetazolamide) |"
    },
    {
      "type": "table",
      "section": "ANION GAP (AG)",
      "line": 317,
      "preview": "| $\\mathbf{A}$ | Adrenal insufficiency/aldosterone deficiency |"
    },
    {
      "type": "table",
      "section": "ANION GAP (AG)",
      "line": 318,
      "preview": "| $\\mathbf{R}$ | Renal tubular acidosis |"
    },
    {
      "type": "text",
      "section": "ANION GAP (AG)",
      "line": 320,
      "preview": "Ayers P et al. Nutr Clin Pract. 2014; 30:14-20."
    },
    {
      "type": "text",
      "section": "ANION GAP (AG)",
      "line": 321,
      "preview": "Adrogue HJ et al. Kidney Int. 2009; 76:1239-47."
    },
    {
      "type": "text",
      "section": "ANION GAP (AG)",
      "line": 322,
      "preview": "Al-Jaghbeer M, Kellum JA. Nephrol Dial Transplant. 2015; 30:1104-11."
    },
    {
      "type": "text",
      "section": "ANION GAP (AG)",
      "line": 324,
      "preview": "--- page 13 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "URINE EVALUATION",
      "line": 326
    },
    {
      "type": "text",
      "section": "URINE EVALUATION",
      "line": 328,
      "preview": "- Urine chemistries and urine pH are helpful in identifying specific types of renal tubular disorder"
    },
    {
      "type": "text",
      "section": "URINE EVALUATION",
      "line": 329,
      "preview": "- Urinary anion gap (UAG) $=\\left(\\mathrm{UNa}^{+}+\\mathrm{UK}^{+}\\right)-\\mathrm{UCl}^{-}=0 \\mathrm"
    },
    {
      "type": "table",
      "section": "URINE EVALUATION",
      "line": 331,
      "preview": "| UAG | Serum K | Urine pH | Diagnosis |"
    },
    {
      "type": "table",
      "section": "URINE EVALUATION",
      "line": 332,
      "preview": "| :--: | :--: | :--: | :--: |"
    },
    {
      "type": "table",
      "section": "URINE EVALUATION",
      "line": 333,
      "preview": "| Negative | Normal | $<5.5$ | Normal |"
    },
    {
      "type": "table",
      "section": "URINE EVALUATION",
      "line": 334,
      "preview": "| Negative | Normal/Low | $>5.5$ | Gl bicarbonate loss |"
    },
    {
      "type": "table",
      "section": "URINE EVALUATION",
      "line": 335,
      "preview": "| Positive | Elevated | $<5.5$ | Selective Aldosterone Deficiency |"
    },
    {
      "type": "table",
      "section": "URINE EVALUATION",
      "line": 336,
      "preview": "| Positive | Normal/Low | $>5.5$ | Classic RTA |"
    },
    {
      "type": "table",
      "section": "URINE EVALUATION",
      "line": 337,
      "preview": "| Positive | Elevated | $>5.5$ | Hyperkalemic Distal RTA |"
    },
    {
      "type": "text",
      "section": "URINE EVALUATION",
      "line": 339,
      "preview": "Batlle, et al. N Engl J Med 1988;318:594-599."
    },
    {
      "type": "text",
      "section": "URINE EVALUATION",
      "line": 341,
      "preview": "Etiology: Elevated-Anion Gap Metabolic Acidosis"
    },
    {
      "type": "table",
      "section": "URINE EVALUATION",
      "line": 343,
      "preview": "| $\\mathbf{M}$ | Methanol ingestion |"
    },
    {
      "type": "table",
      "section": "URINE EVALUATION",
      "line": 344,
      "preview": "| :--: | :-- |"
    },
    {
      "type": "table",
      "section": "URINE EVALUATION",
      "line": 345,
      "preview": "| $\\mathbf{U}$ | Uremia (renal failure) |"
    },
    {
      "type": "table",
      "section": "URINE EVALUATION",
      "line": 346,
      "preview": "| $\\mathbf{D}$ | Diabetic ketoacidosis (alcohol and starvation ketoacidosis) |"
    },
    {
      "type": "table",
      "section": "URINE EVALUATION",
      "line": 347,
      "preview": "| $\\mathbf{P}$ | Propylene glycol ingestion |"
    },
    {
      "type": "table",
      "section": "URINE EVALUATION",
      "line": 348,
      "preview": "| $\\mathbf{I}$ | Isoniazid |"
    },
    {
      "type": "table",
      "section": "URINE EVALUATION",
      "line": 349,
      "preview": "| $\\mathbf{L}$ | Lactic acidosis |"
    },
    {
      "type": "table",
      "section": "URINE EVALUATION",
      "line": 350,
      "preview": "| $\\mathbf{E}$ | Ethylene glycol ingestion |"
    },
    {
      "type": "table",
      "section": "URINE EVALUATION",
      "line": 351,
      "preview": "| $\\mathbf{S}$ | Salicylate overdose |"
    },
    {
      "type": "text",
      "section": "URINE EVALUATION",
      "line": 353,
      "preview": "Ayers P et al. Nutr Clin Pract. 2014; 30:14-20."
    },
    {
      "type": "text",
      "section": "URINE EVALUATION",
      "line": 354,
      "preview": "Adrogue HJ et al. Kidney Int. 2009; 76:1239-47."
    },
    {
      "type": "text",
      "section": "URINE EVALUATION",
      "line": 355,
      "preview": "Al-Jaghbeer M, Kellum JA. Nephrol Dial Transplant. 2015; 30:1104-11."
    },
    {
      "type": "text",
      "section": "URINE EVALUATION",
      "line": 357,
      "preview": "--- page 14 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "METABOLIC ACIDOSIS TREATMENT",
      "line": 359
    },
    {
      "type": "text",
      "section": "METABOLIC ACIDOSIS TREATMENT",
      "line": 361,
      "preview": "- Identify and treat/remove underlying cause(s)"
    },
    {
      "type": "text",
      "section": "METABOLIC ACIDOSIS TREATMENT",
      "line": 362,
      "preview": "- Steroids (adrenal insufficiency)"
    },
    {
      "type": "text",
      "section": "METABOLIC ACIDOSIS TREATMENT",
      "line": 363,
      "preview": "- Antidiarrhea, antisecretory agents (diarrhea/fistula)"
    },
    {
      "type": "text",
      "section": "METABOLIC ACIDOSIS TREATMENT",
      "line": 364,
      "preview": "- Discontinue chloride-based fluids"
    },
    {
      "type": "text",
      "section": "METABOLIC ACIDOSIS TREATMENT",
      "line": 365,
      "preview": "- Adjust PN to have higher acetate:chloride salt ratio"
    },
    {
      "type": "text",
      "section": "METABOLIC ACIDOSIS TREATMENT",
      "line": 366,
      "preview": "- Fluid resuscitation, insulin (diabetic ketoacidosis)"
    },
    {
      "type": "text",
      "section": "METABOLIC ACIDOSIS TREATMENT",
      "line": 367,
      "preview": "- Fluid resuscitation, antimicrobial agents (sepsis)"
    },
    {
      "type": "text",
      "section": "METABOLIC ACIDOSIS TREATMENT",
      "line": 368,
      "preview": "- Bicarbonate replacement (oral or intravenous)"
    },
    {
      "type": "text",
      "section": "METABOLIC ACIDOSIS TREATMENT",
      "line": 370,
      "preview": "Ayers P et al. Nutr Clin Pract. 2014; 30:14-20."
    },
    {
      "type": "heading",
      "level": 2,
      "section": "SELF-ASSESSMENT \\#3",
      "line": 372
    },
    {
      "type": "text",
      "section": "SELF-ASSESSMENT \\#3",
      "line": 374,
      "preview": "A patient presents with a metabolic acidosis due to high volume diarrhea. What is the appropriate co"
    },
    {
      "type": "text",
      "section": "SELF-ASSESSMENT \\#3",
      "line": 375,
      "preview": "A. Increase in respiratory rate"
    },
    {
      "type": "text",
      "section": "SELF-ASSESSMENT \\#3",
      "line": 376,
      "preview": "B. Decrease in respiratory rate"
    },
    {
      "type": "text",
      "section": "SELF-ASSESSMENT \\#3",
      "line": 377,
      "preview": "C. Increase bicarbonate reabsorption"
    },
    {
      "type": "text",
      "section": "SELF-ASSESSMENT \\#3",
      "line": 378,
      "preview": "D. Decrease bicarbonate reabsorption"
    },
    {
      "type": "text",
      "section": "SELF-ASSESSMENT \\#3",
      "line": 380,
      "preview": "--- page 15 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "METABOLIC ALKALOSIS",
      "line": 382
    },
    {
      "type": "text",
      "section": "METABOLIC ALKALOSIS",
      "line": 384,
      "preview": "- Increased $\\mathrm{pH}(>7.45$ ) due to increased plasma $\\mathrm{HCO}_{3}^{-}(>24 \\mathrm{mEq} / \\"
    },
    {
      "type": "text",
      "section": "METABOLIC ALKALOSIS",
      "line": 385,
      "preview": "- Excessive loss of $\\mathrm{H}^{+}$from the kidney or stomach"
    },
    {
      "type": "text",
      "section": "METABOLIC ALKALOSIS",
      "line": 386,
      "preview": "- Ingestion/administration of bicarbonate-rich fluids"
    },
    {
      "type": "text",
      "section": "METABOLIC ALKALOSIS",
      "line": 387,
      "preview": "- Loss of fluid containing chloride"
    },
    {
      "type": "text",
      "section": "METABOLIC ALKALOSIS",
      "line": 388,
      "preview": "- Pulmonary compensation"
    },
    {
      "type": "text",
      "section": "METABOLIC ALKALOSIS",
      "line": 389,
      "preview": "- Decrease respiratory rate"
    },
    {
      "type": "text",
      "section": "METABOLIC ALKALOSIS",
      "line": 390,
      "preview": "- Increase $\\mathrm{pCO}_{2}$"
    },
    {
      "type": "text",
      "section": "METABOLIC ALKALOSIS",
      "line": 391,
      "preview": "- Classified as saline responsive ( $\\mathrm{uCl}<10 \\mathrm{mEq} / \\mathrm{L}$ ) and saline resista"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "ETIOLOGY",
      "line": 394
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Saline-responsive",
      "line": 396
    },
    {
      "type": "text",
      "section": "Saline-responsive",
      "line": 398,
      "preview": "- Diuretics (loops and thiazides)"
    },
    {
      "type": "text",
      "section": "Saline-responsive",
      "line": 399,
      "preview": "- Gastric losses (emesis, nasogastric suction, gastric tube losses)"
    },
    {
      "type": "text",
      "section": "Saline-responsive",
      "line": 400,
      "preview": "- Exogenous alkali administration (acetate salts in PN, bicarbonate infusions, Ringers lactate)"
    },
    {
      "type": "text",
      "section": "Saline-responsive",
      "line": 401,
      "preview": "- Alkalosis associated with mild hypokalemia"
    },
    {
      "type": "text",
      "section": "Saline-responsive",
      "line": 402,
      "preview": "- Villous adenoma of the colon"
    },
    {
      "type": "text",
      "section": "Saline-responsive",
      "line": 404,
      "preview": "Ayers P et al. Nutr Clin Pract. 2014; 30:14-20."
    },
    {
      "type": "text",
      "section": "Saline-responsive",
      "line": 405,
      "preview": "Adrogue HJ et al. Kidney Int. 2009; 76:1239-47."
    },
    {
      "type": "text",
      "section": "Saline-responsive",
      "line": 406,
      "preview": "Al-Jaghbeer M, Kellum JA. Nephrol Dial Transplant. 2015; 30:1104-11."
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Saline-resistant",
      "line": 408
    },
    {
      "type": "text",
      "section": "Saline-resistant",
      "line": 410,
      "preview": "- Normotensive patients"
    },
    {
      "type": "text",
      "section": "Saline-resistant",
      "line": 411,
      "preview": "- Potassium depletion"
    },
    {
      "type": "text",
      "section": "Saline-resistant",
      "line": 412,
      "preview": "- Hypercalcemia"
    },
    {
      "type": "text",
      "section": "Saline-resistant",
      "line": 413,
      "preview": "- Hypertensive patients"
    },
    {
      "type": "text",
      "section": "Saline-resistant",
      "line": 414,
      "preview": "- Mineralocorticoid excess"
    },
    {
      "type": "text",
      "section": "Saline-resistant",
      "line": 415,
      "preview": "- Large licorice intake"
    },
    {
      "type": "text",
      "section": "Saline-resistant",
      "line": 417,
      "preview": "--- page 16 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "METABOLIC ALKALOSIS TREATMENT",
      "line": 419
    },
    {
      "type": "text",
      "section": "METABOLIC ALKALOSIS TREATMENT",
      "line": 421,
      "preview": "- Identify and treat/remove underlying cause(s)"
    },
    {
      "type": "text",
      "section": "METABOLIC ALKALOSIS TREATMENT",
      "line": 422,
      "preview": "- Volume replacement"
    },
    {
      "type": "text",
      "section": "METABOLIC ALKALOSIS TREATMENT",
      "line": 423,
      "preview": "- Discontinue bicarbonate (acetate)-based fluids"
    },
    {
      "type": "text",
      "section": "METABOLIC ALKALOSIS TREATMENT",
      "line": 424,
      "preview": "- Adjust PN to have higher chloride:acetate salt ratio"
    },
    {
      "type": "text",
      "section": "METABOLIC ALKALOSIS TREATMENT",
      "line": 425,
      "preview": "- Antiemetics, acid suppressive therapy (emesis, high NG output)"
    },
    {
      "type": "text",
      "section": "METABOLIC ALKALOSIS TREATMENT",
      "line": 426,
      "preview": "- Potassium replacement"
    },
    {
      "type": "text",
      "section": "METABOLIC ALKALOSIS TREATMENT",
      "line": 427,
      "preview": "- Carbonic anhydrase inhibitors (acetazolamide)"
    },
    {
      "type": "text",
      "section": "METABOLIC ALKALOSIS TREATMENT",
      "line": 428,
      "preview": "- Spironolactone (mineralocorticoid excess)"
    },
    {
      "type": "text",
      "section": "METABOLIC ALKALOSIS TREATMENT",
      "line": 429,
      "preview": "- Hydrochloric acid (severe cases)"
    },
    {
      "type": "text",
      "section": "METABOLIC ALKALOSIS TREATMENT",
      "line": 431,
      "preview": "Ayers P et al. Nutr Clin Pract. 2014; 30:14-20."
    },
    {
      "type": "heading",
      "level": 2,
      "section": "SELF-ASSESSMENT \\#4",
      "line": 433
    },
    {
      "type": "text",
      "section": "SELF-ASSESSMENT \\#4",
      "line": 435,
      "preview": "Which of the following diuretics is NOT associated with metabolic alkalosis?"
    },
    {
      "type": "text",
      "section": "SELF-ASSESSMENT \\#4",
      "line": 436,
      "preview": "A. Hydrochlorothiazide"
    },
    {
      "type": "text",
      "section": "SELF-ASSESSMENT \\#4",
      "line": 437,
      "preview": "B. Bumetanide"
    },
    {
      "type": "text",
      "section": "SELF-ASSESSMENT \\#4",
      "line": 438,
      "preview": "C. Acetazolamide"
    },
    {
      "type": "text",
      "section": "SELF-ASSESSMENT \\#4",
      "line": 439,
      "preview": "D. Furosemide"
    },
    {
      "type": "text",
      "section": "SELF-ASSESSMENT \\#4",
      "line": 441,
      "preview": "--- page 17 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "RESPIRATORY ACIDOSIS",
      "line": 443
    },
    {
      "type": "text",
      "section": "RESPIRATORY ACIDOSIS",
      "line": 445,
      "preview": "- Decreased pH ( $<7.35$ ) due to increased $\\mathrm{pCO}_{2}$ ( $>40 \\mathrm{mmHg}$ )"
    },
    {
      "type": "text",
      "section": "RESPIRATORY ACIDOSIS",
      "line": 446,
      "preview": "- Respiratory failure"
    },
    {
      "type": "text",
      "section": "RESPIRATORY ACIDOSIS",
      "line": 447,
      "preview": "- Inadequate excretion of $\\mathrm{pCO}_{2}$"
    },
    {
      "type": "text",
      "section": "RESPIRATORY ACIDOSIS",
      "line": 448,
      "preview": "- Renal compensation"
    },
    {
      "type": "text",
      "section": "RESPIRATORY ACIDOSIS",
      "line": 449,
      "preview": "- Decreased bicarbonate excretion (increasing $\\mathrm{HCO}_{3}{ }^{-}$)"
    },
    {
      "type": "text",
      "section": "RESPIRATORY ACIDOSIS",
      "line": 450,
      "preview": "- Acute versus chronic"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "RESPIRATORY ACIDOSIS ETIOLOGY",
      "line": 453
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Acute Respiratory Acidosis",
      "line": 455
    },
    {
      "type": "text",
      "section": "Acute Respiratory Acidosis",
      "line": 457,
      "preview": "- Acute airway disorders (airway obstruction, asthma/COPD exacerbation)"
    },
    {
      "type": "text",
      "section": "Acute Respiratory Acidosis",
      "line": 458,
      "preview": "- Acute central nervous system depression (drug overdose, head trauma, stroke, infections)"
    },
    {
      "type": "text",
      "section": "Acute Respiratory Acidosis",
      "line": 459,
      "preview": "- Acute neuromuscular disorders (Guillain-Barre, spinal cord injury, neuromuscular blocking agents)"
    },
    {
      "type": "text",
      "section": "Acute Respiratory Acidosis",
      "line": 460,
      "preview": "- Acute respiratory disorder (pneumonia, pulmonary edema, pulmonary embolus, hemothorax, pneumothora"
    },
    {
      "type": "text",
      "section": "Acute Respiratory Acidosis",
      "line": 462,
      "preview": "--- page 18 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "RESPIRATORY ACIDOSIS ETIOLOGY",
      "line": 464
    },
    {
      "type": "heading",
      "level": 2,
      "section": "Chronic Respiratory Acidosis",
      "line": 466
    },
    {
      "type": "text",
      "section": "Chronic Respiratory Acidosis",
      "line": 468,
      "preview": "- Asthma"
    },
    {
      "type": "text",
      "section": "Chronic Respiratory Acidosis",
      "line": 469,
      "preview": "- COPD, emphysema"
    },
    {
      "type": "text",
      "section": "Chronic Respiratory Acidosis",
      "line": 470,
      "preview": "- Obstructive sleep apnea"
    },
    {
      "type": "text",
      "section": "Chronic Respiratory Acidosis",
      "line": 471,
      "preview": "- Hypoventilation syndromes"
    },
    {
      "type": "text",
      "section": "Chronic Respiratory Acidosis",
      "line": 472,
      "preview": "- Diaphragmatic paralysis"
    },
    {
      "type": "text",
      "section": "Chronic Respiratory Acidosis",
      "line": 473,
      "preview": "- Myasthenia gravis"
    },
    {
      "type": "text",
      "section": "Chronic Respiratory Acidosis",
      "line": 474,
      "preview": "- Amyotrophic lateral sclerosis"
    },
    {
      "type": "text",
      "section": "Chronic Respiratory Acidosis",
      "line": 475,
      "preview": "- Spinal cord injury"
    },
    {
      "type": "text",
      "section": "Chronic Respiratory Acidosis",
      "line": 476,
      "preview": "- Multiple sclerosis"
    },
    {
      "type": "text",
      "section": "Chronic Respiratory Acidosis",
      "line": 477,
      "preview": "- Muscular dystrophy"
    },
    {
      "type": "text",
      "section": "Chronic Respiratory Acidosis",
      "line": 478,
      "preview": "- Poliomyelitis"
    },
    {
      "type": "text",
      "section": "Chronic Respiratory Acidosis",
      "line": 479,
      "preview": "- Kyphoscoliosis"
    },
    {
      "type": "text",
      "section": "Chronic Respiratory Acidosis",
      "line": 480,
      "preview": "- Hypothyroidism"
    },
    {
      "type": "text",
      "section": "Chronic Respiratory Acidosis",
      "line": 482,
      "preview": "Ayers P et al. Nutr Clin Pract. 2014; 30:14-20."
    },
    {
      "type": "text",
      "section": "Chronic Respiratory Acidosis",
      "line": 483,
      "preview": "Adrogue, HJ et al. Kidney Int. 2009; 76:1239-47."
    },
    {
      "type": "text",
      "section": "Chronic Respiratory Acidosis",
      "line": 484,
      "preview": "Al-Jaghbeer M, Kellum JA. Nephrol Dial Transplant. 2015; 30:1104-11."
    },
    {
      "type": "heading",
      "level": 2,
      "section": "RESPIRATORY ACIDOSIS TREATMENT",
      "line": 486
    },
    {
      "type": "text",
      "section": "RESPIRATORY ACIDOSIS TREATMENT",
      "line": 488,
      "preview": "- Identify and treat/remove underlying cause(s)"
    },
    {
      "type": "text",
      "section": "RESPIRATORY ACIDOSIS TREATMENT",
      "line": 489,
      "preview": "- Ventilatory support"
    },
    {
      "type": "text",
      "section": "RESPIRATORY ACIDOSIS TREATMENT",
      "line": 490,
      "preview": "- Respiratory treatments"
    },
    {
      "type": "text",
      "section": "RESPIRATORY ACIDOSIS TREATMENT",
      "line": 491,
      "preview": "- Antimicrobial therapy (as appropriate)"
    },
    {
      "type": "text",
      "section": "RESPIRATORY ACIDOSIS TREATMENT",
      "line": 492,
      "preview": "- Antidotes (overdose)"
    },
    {
      "type": "text",
      "section": "RESPIRATORY ACIDOSIS TREATMENT",
      "line": 493,
      "preview": "- Alkali therapy in severe acidosis"
    },
    {
      "type": "text",
      "section": "RESPIRATORY ACIDOSIS TREATMENT",
      "line": 495,
      "preview": "--- page 19 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "RESPIRATORY ALKALOSIS",
      "line": 497
    },
    {
      "type": "text",
      "section": "RESPIRATORY ALKALOSIS",
      "line": 499,
      "preview": "- Increased $\\mathrm{pH}(>7.45)$ due to decreased $\\mathrm{pCO}_{2}(<40 \\mathrm{mmHg})$"
    },
    {
      "type": "text",
      "section": "RESPIRATORY ALKALOSIS",
      "line": 500,
      "preview": "- Respiratory stimulation"
    },
    {
      "type": "text",
      "section": "RESPIRATORY ALKALOSIS",
      "line": 501,
      "preview": "- Increase exhalation of $\\mathrm{pCO}_{2}$"
    },
    {
      "type": "text",
      "section": "RESPIRATORY ALKALOSIS",
      "line": 502,
      "preview": "- Renal compensation"
    },
    {
      "type": "text",
      "section": "RESPIRATORY ALKALOSIS",
      "line": 503,
      "preview": "- Increased bicarbonate excretion (decreasing $\\mathrm{HCO}_{3}{ }^{-}$)"
    },
    {
      "type": "text",
      "section": "RESPIRATORY ALKALOSIS",
      "line": 504,
      "preview": "- Acute versus chronic"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "RESPIRATORY ALKALOSIS ETIOLOGY",
      "line": 507
    },
    {
      "type": "text",
      "section": "RESPIRATORY ALKALOSIS ETIOLOGY",
      "line": 509,
      "preview": "- Central nervous system disorders"
    },
    {
      "type": "text",
      "section": "RESPIRATORY ALKALOSIS ETIOLOGY",
      "line": 510,
      "preview": "- Anxiety, pain, infections, head trauma, malignancy, cerebrovascular disease"
    },
    {
      "type": "text",
      "section": "RESPIRATORY ALKALOSIS ETIOLOGY",
      "line": 511,
      "preview": "- Hypoxia, high altitude"
    },
    {
      "type": "text",
      "section": "RESPIRATORY ALKALOSIS ETIOLOGY",
      "line": 512,
      "preview": "- Lung disorder"
    },
    {
      "type": "text",
      "section": "RESPIRATORY ALKALOSIS ETIOLOGY",
      "line": 513,
      "preview": "- Pneumonia, pulmonary edema, pulmonary embolism, asthma, hyperventilation, interstitial fibrosis"
    },
    {
      "type": "text",
      "section": "RESPIRATORY ALKALOSIS ETIOLOGY",
      "line": 514,
      "preview": "- Mechanical ventilation"
    },
    {
      "type": "text",
      "section": "RESPIRATORY ALKALOSIS ETIOLOGY",
      "line": 516,
      "preview": "--- page 20 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "RESPIRATORY ALKALOSIS ETIOLOGY, CONT.",
      "line": 518
    },
    {
      "type": "text",
      "section": "RESPIRATORY ALKALOSIS ETIOLOGY, CONT.",
      "line": 520,
      "preview": "- Medications"
    },
    {
      "type": "text",
      "section": "RESPIRATORY ALKALOSIS ETIOLOGY, CONT.",
      "line": 521,
      "preview": "- Xanthine derivatives, nicotine, catecholamines, salicylates"
    },
    {
      "type": "text",
      "section": "RESPIRATORY ALKALOSIS ETIOLOGY, CONT.",
      "line": 522,
      "preview": "- Pregnancy"
    },
    {
      "type": "text",
      "section": "RESPIRATORY ALKALOSIS ETIOLOGY, CONT.",
      "line": 523,
      "preview": "- Cirrhosis"
    },
    {
      "type": "text",
      "section": "RESPIRATORY ALKALOSIS ETIOLOGY, CONT.",
      "line": 524,
      "preview": "- Sepsis"
    },
    {
      "type": "text",
      "section": "RESPIRATORY ALKALOSIS ETIOLOGY, CONT.",
      "line": 526,
      "preview": "Ayers P et al. Nutr Clin Pract. 2014; 30:14-20."
    },
    {
      "type": "text",
      "section": "RESPIRATORY ALKALOSIS ETIOLOGY, CONT.",
      "line": 527,
      "preview": "Adrogue, HJ et al. Kidney Int. 2009; 76:1239-47."
    },
    {
      "type": "text",
      "section": "RESPIRATORY ALKALOSIS ETIOLOGY, CONT.",
      "line": 528,
      "preview": "Al-Jaghbeer M, Kellum JA. Nephrol Dial Transplant. 2015; 30:1104-11."
    },
    {
      "type": "heading",
      "level": 2,
      "section": "RESPIRATORY ALKALOSIS TREATMENT",
      "line": 530
    },
    {
      "type": "text",
      "section": "RESPIRATORY ALKALOSIS TREATMENT",
      "line": 532,
      "preview": "- Identify and treat/remove underlying cause(s)"
    },
    {
      "type": "text",
      "section": "RESPIRATORY ALKALOSIS TREATMENT",
      "line": 533,
      "preview": "- Ventilator support"
    },
    {
      "type": "text",
      "section": "RESPIRATORY ALKALOSIS TREATMENT",
      "line": 534,
      "preview": "- Respiratory depressants"
    },
    {
      "type": "text",
      "section": "RESPIRATORY ALKALOSIS TREATMENT",
      "line": 535,
      "preview": "- Reassurance"
    },
    {
      "type": "text",
      "section": "RESPIRATORY ALKALOSIS TREATMENT",
      "line": 536,
      "preview": "- Antimicrobial therapy (as appropriate)"
    },
    {
      "type": "text",
      "section": "RESPIRATORY ALKALOSIS TREATMENT",
      "line": 538,
      "preview": "--- page 21 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "SELF-ASSESSMENT \\#1",
      "line": 540
    },
    {
      "type": "text",
      "section": "SELF-ASSESSMENT \\#1",
      "line": 542,
      "preview": "- RK is a 55 year old male home PN patient who presents to the Emergency Department for hypovolemia "
    },
    {
      "type": "text",
      "section": "SELF-ASSESSMENT \\#1",
      "line": 543,
      "preview": "- Laboratory values:"
    },
    {
      "type": "table",
      "section": "SELF-ASSESSMENT \\#1",
      "line": 545,
      "preview": "| Na: $139 \\mathrm{mEq} / \\mathrm{L}$ | Glucose: $122 \\mathrm{mg} / \\mathrm{dL}$ |"
    },
    {
      "type": "table",
      "section": "SELF-ASSESSMENT \\#1",
      "line": 546,
      "preview": "| :--: | :--: |"
    },
    {
      "type": "table",
      "section": "SELF-ASSESSMENT \\#1",
      "line": 547,
      "preview": "| K: $3.7 \\mathrm{mEq} / \\mathrm{L}$ | ABG: |"
    },
    {
      "type": "table",
      "section": "SELF-ASSESSMENT \\#1",
      "line": 548,
      "preview": "| Cl: $98 \\mathrm{mEq} / \\mathrm{L}$ | $\\mathrm{pH}: 7.46$ |"
    },
    {
      "type": "table",
      "section": "SELF-ASSESSMENT \\#1",
      "line": 549,
      "preview": "| $\\mathrm{CO}_{2}: 34 \\mathrm{mEq} / \\mathrm{L}$ | $\\mathrm{pCO}_{2}: 46 \\mathrm{mmHg}$ |"
    },
    {
      "type": "table",
      "section": "SELF-ASSESSMENT \\#1",
      "line": 550,
      "preview": "| BUN: $21 \\mathrm{mg} / \\mathrm{dL}$ | $\\mathrm{PO}_{2}: 92 \\mathrm{mmHg}$ |"
    },
    {
      "type": "table",
      "section": "SELF-ASSESSMENT \\#1",
      "line": 551,
      "preview": "| Cr: $0.9 \\mathrm{mg} / \\mathrm{dL}$ | $\\mathrm{HCO}_{3}{ }^{-}: 34 \\mathrm{mmol} / \\mathrm{L}$ |"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "SELF-ASSESSMENT \\#1, CONT.",
      "line": 553
    },
    {
      "type": "text",
      "section": "SELF-ASSESSMENT \\#1, CONT.",
      "line": 555,
      "preview": "Upon admission to the hospital and continuation of PN, what change should be made based on RK's ABG?"
    },
    {
      "type": "text",
      "section": "SELF-ASSESSMENT \\#1, CONT.",
      "line": 556,
      "preview": "A. Initiate mechanical ventilation"
    },
    {
      "type": "text",
      "section": "SELF-ASSESSMENT \\#1, CONT.",
      "line": 557,
      "preview": "B. Increase chloride salts in the PN"
    },
    {
      "type": "text",
      "section": "SELF-ASSESSMENT \\#1, CONT.",
      "line": 558,
      "preview": "C. Increase acetate salts in the PN"
    },
    {
      "type": "text",
      "section": "SELF-ASSESSMENT \\#1, CONT.",
      "line": 559,
      "preview": "D. Decrease calorie content of PN"
    },
    {
      "type": "text",
      "section": "SELF-ASSESSMENT \\#1, CONT.",
      "line": 561,
      "preview": "--- page 22 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "SELF-ASSESSMENT \\#1, CONT.",
      "line": 563
    },
    {
      "type": "text",
      "section": "SELF-ASSESSMENT \\#1, CONT.",
      "line": 565,
      "preview": "Upon admission to the hospital and continuation of PN, what change should be made based on RK's ABG?"
    },
    {
      "type": "text",
      "section": "SELF-ASSESSMENT \\#1, CONT.",
      "line": 566,
      "preview": "A. Initiate mechanical ventilation"
    },
    {
      "type": "text",
      "section": "SELF-ASSESSMENT \\#1, CONT.",
      "line": 567,
      "preview": "B. Increase chloride salts in the PN"
    },
    {
      "type": "text",
      "section": "SELF-ASSESSMENT \\#1, CONT.",
      "line": 568,
      "preview": "C. Increase acetate salts in the PN"
    },
    {
      "type": "text",
      "section": "SELF-ASSESSMENT \\#1, CONT.",
      "line": 569,
      "preview": "D. Decrease calorie content of PN"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "SELF-ASSESSMENT \\#2",
      "line": 571
    },
    {
      "type": "text",
      "section": "SELF-ASSESSMENT \\#2",
      "line": 573,
      "preview": "A patient presents with a metabolic acidosis due to septic shock. Which ABG pattern fits this disord"
    },
    {
      "type": "text",
      "section": "SELF-ASSESSMENT \\#2",
      "line": 574,
      "preview": "A. Decreased pH , decreased $\\mathrm{HCO}_{3}{ }^{-}$"
    },
    {
      "type": "text",
      "section": "SELF-ASSESSMENT \\#2",
      "line": 575,
      "preview": "B. Decreased pH , increased $\\mathrm{PCO}_{2}$"
    },
    {
      "type": "text",
      "section": "SELF-ASSESSMENT \\#2",
      "line": 576,
      "preview": "C. Increased pH , increased $\\mathrm{HCO}_{3}{ }^{-}$"
    },
    {
      "type": "text",
      "section": "SELF-ASSESSMENT \\#2",
      "line": 577,
      "preview": "D. Increased pH , decreased $\\mathrm{PCO}_{2}$"
    },
    {
      "type": "text",
      "section": "SELF-ASSESSMENT \\#2",
      "line": 579,
      "preview": "--- page 23 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "SELF-ASSESSMENT \\#2",
      "line": 581
    },
    {
      "type": "text",
      "section": "SELF-ASSESSMENT \\#2",
      "line": 583,
      "preview": "A patient presents with a metabolic acidosis due to septic shock. Which ABG pattern fits this disord"
    },
    {
      "type": "text",
      "section": "SELF-ASSESSMENT \\#2",
      "line": 584,
      "preview": "A. Decreased $\\mathrm{pH}, \\operatorname{decreased} \\mathrm{HCO}_{3}{ }^{-}$"
    },
    {
      "type": "text",
      "section": "SELF-ASSESSMENT \\#2",
      "line": 585,
      "preview": "B. Decreased pH , increased $\\mathrm{PCO}_{2}$"
    },
    {
      "type": "text",
      "section": "SELF-ASSESSMENT \\#2",
      "line": 586,
      "preview": "C. Increased pH , increased $\\mathrm{HCO}_{3}{ }^{-}$"
    },
    {
      "type": "text",
      "section": "SELF-ASSESSMENT \\#2",
      "line": 587,
      "preview": "D. Increased pH , decreased $\\mathrm{PCO}_{2}$"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "SELF-ASSESSMENT \\#3",
      "line": 589
    },
    {
      "type": "text",
      "section": "SELF-ASSESSMENT \\#3",
      "line": 591,
      "preview": "A patient presents with a metabolic acidosis due to high volume diarrhea. What is the appropriate co"
    },
    {
      "type": "text",
      "section": "SELF-ASSESSMENT \\#3",
      "line": 592,
      "preview": "A. Increase in respiratory rate"
    },
    {
      "type": "text",
      "section": "SELF-ASSESSMENT \\#3",
      "line": 593,
      "preview": "B. Decrease in respiratory rate"
    },
    {
      "type": "text",
      "section": "SELF-ASSESSMENT \\#3",
      "line": 594,
      "preview": "C. Increase bicarbonate reabsorption"
    },
    {
      "type": "text",
      "section": "SELF-ASSESSMENT \\#3",
      "line": 595,
      "preview": "D. Decrease bicarbonate reabsorption"
    },
    {
      "type": "text",
      "section": "SELF-ASSESSMENT \\#3",
      "line": 597,
      "preview": "--- page 24 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "SELF-ASSESSMENT \\#3",
      "line": 599
    },
    {
      "type": "text",
      "section": "SELF-ASSESSMENT \\#3",
      "line": 601,
      "preview": "A patient presents with a metabolic acidosis due to high volume diarrhea. What is the appropriate co"
    },
    {
      "type": "text",
      "section": "SELF-ASSESSMENT \\#3",
      "line": 602,
      "preview": "A. Increase in respiratory rate"
    },
    {
      "type": "text",
      "section": "SELF-ASSESSMENT \\#3",
      "line": 603,
      "preview": "B. Decrease in respiratory rate"
    },
    {
      "type": "text",
      "section": "SELF-ASSESSMENT \\#3",
      "line": 604,
      "preview": "C. Increase bicarbonate reabsorption"
    },
    {
      "type": "text",
      "section": "SELF-ASSESSMENT \\#3",
      "line": 605,
      "preview": "D. Decrease bicarbonate reabsorption"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "SELF-ASSESSMENT \\#4",
      "line": 607
    },
    {
      "type": "text",
      "section": "SELF-ASSESSMENT \\#4",
      "line": 609,
      "preview": "Which of the following diuretics is NOT associated with metabolic alkalosis?"
    },
    {
      "type": "text",
      "section": "SELF-ASSESSMENT \\#4",
      "line": 610,
      "preview": "A. Hydrochlorothiazide"
    },
    {
      "type": "text",
      "section": "SELF-ASSESSMENT \\#4",
      "line": 611,
      "preview": "B. Bumetanide"
    },
    {
      "type": "text",
      "section": "SELF-ASSESSMENT \\#4",
      "line": 612,
      "preview": "C. Acetazolamide"
    },
    {
      "type": "text",
      "section": "SELF-ASSESSMENT \\#4",
      "line": 613,
      "preview": "D. Furosemide"
    },
    {
      "type": "text",
      "section": "SELF-ASSESSMENT \\#4",
      "line": 615,
      "preview": "--- page 25 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "SELF-ASSESSMENT \\#4",
      "line": 617
    },
    {
      "type": "text",
      "section": "SELF-ASSESSMENT \\#4",
      "line": 619,
      "preview": "Which of the following diuretics is NOT associated with metabolic alkalosis?"
    },
    {
      "type": "text",
      "section": "SELF-ASSESSMENT \\#4",
      "line": 620,
      "preview": "A. Hydrochlorothiazide"
    },
    {
      "type": "text",
      "section": "SELF-ASSESSMENT \\#4",
      "line": 621,
      "preview": "B. Bumetanide"
    },
    {
      "type": "text",
      "section": "SELF-ASSESSMENT \\#4",
      "line": 622,
      "preview": "C. Acetazolamide"
    },
    {
      "type": "text",
      "section": "SELF-ASSESSMENT \\#4",
      "line": 623,
      "preview": "D. Furosemide"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "CONCLUSIONS",
      "line": 625
    },
    {
      "type": "text",
      "section": "CONCLUSIONS",
      "line": 627,
      "preview": "- A thorough history and physical, including medication review, is important for identification and "
    },
    {
      "type": "text",
      "section": "CONCLUSIONS",
      "line": 628,
      "preview": "- Knowledge of causes of acid-base disorders will help in determining appropriate prevention and tre"
    },
    {
      "type": "text",
      "section": "CONCLUSIONS",
      "line": 629,
      "preview": "- Development of a nutrition care plan should be done using a systematic approach including comorbid"
    },
    {
      "type": "text",
      "section": "CONCLUSIONS",
      "line": 631,
      "preview": "--- page 26 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "REFERENCES",
      "line": 633
    },
    {
      "type": "text",
      "section": "REFERENCES",
      "line": 635,
      "preview": "- Adrogue, HJ, Gennari FJ, Galla JH et al. Assessing acid-base disorders. Kidney Int. 2009; 76:1239-"
    },
    {
      "type": "text",
      "section": "REFERENCES",
      "line": 636,
      "preview": "- Al-Jaghbeer M and Kellum JA. Acid-base disturbances in intensive unit patients: etiology, pathophy"
    },
    {
      "type": "text",
      "section": "REFERENCES",
      "line": 637,
      "preview": "- Ayers P and Dixon C. Simple acid-base tutorial. JPEN J Parent Enteral Nutr. 2012; 36:18-23."
    },
    {
      "type": "text",
      "section": "REFERENCES",
      "line": 638,
      "preview": "- Ayers P, Dixon C, Mays A. Acid-base disorders: learning the basics. Nutr Clin Pract. 2014; 30:14-2"
    },
    {
      "type": "heading",
      "level": 2,
      "section": "REFERENCES, CONT.",
      "line": 641
    },
    {
      "type": "text",
      "section": "REFERENCES, CONT.",
      "line": 643,
      "preview": "- Battle DC, Hizon M, Cohen E, et al. The use of the urinary anion gap in the diagnosis of hyperchlo"
    },
    {
      "type": "text",
      "section": "REFERENCES, CONT.",
      "line": 644,
      "preview": "- Canada TW and Lord LM. Chapter 7 Fluid, Electrolytes, and Acid-Base Disorders. In: Mueller CM, ed."
    },
    {
      "type": "text",
      "section": "REFERENCES, CONT.",
      "line": 645,
      "preview": "- DiPiro JT, Talbert RL, Yee G et al., eds. Pharmacotherapy: a pathophysiologic approach. 8th ed. Ne"
    },
    {
      "type": "text",
      "section": "REFERENCES, CONT.",
      "line": 646,
      "preview": "- Mirtallo J, Canada T, Johnson D et al. Safe practices for parenteral nutrition. JPEN J Parent Ente"
    },
    {
      "type": "text",
      "section": "REFERENCES, CONT.",
      "line": 648,
      "preview": "--- page 27 ---"
    },
    {
      "type": "text",
      "section": "REFERENCES, CONT.",
      "line": 650,
      "preview": "NUTRITION SUPPORT CERTIFICATE"
    },
    {
      "type": "text",
      "section": "REFERENCES, CONT.",
      "line": 652,
      "preview": "--- page 28 ---"
    },
    {
      "type": "image",
      "section": "REFERENCES, CONT.",
      "line": 654,
      "content": "![img-1.jpeg](images/2f51ff233a710ba1.png)"
    },
    {
      "type": "text",
      "section": "REFERENCES, CONT.",
      "line": 656,
      "preview": "Anne M. Tucker, Pharm.D., BCNSP<br>Clinical pharmacy Specialist<br>University of Texas MD Anderson C"
    },
    {
      "type": "text",
      "section": "REFERENCES, CONT.",
      "line": 658,
      "preview": "Anne M. Tucker is clinical pharmacy specialist at the MD Anderson Cancer Center, Houston, Texas. She"
    },
    {
      "type": "text",
      "section": "REFERENCES, CONT.",
      "line": 660,
      "preview": "Dr. Tucker is currently the Chair of the American Society for Parenteral and Enteral Nutrition (ASPE"
    },
    {
      "type": "text",
      "section": "REFERENCES, CONT.",
      "line": 662,
      "preview": "--- page 29 ---"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Relevant Financial Relationship Disclosure",
      "line": 664
    },
    {
      "type": "text",
      "section": "Relevant Financial Relationship Disclosure",
      "line": 666,
      "preview": "In accordance with our accreditor\u2019s Standards of Integrity and Independence in Accredited Continuing"
    },
    {
      "type": "text",
      "section": "Relevant Financial Relationship Disclosure",
      "line": 668,
      "preview": "An ineligible company is any entity producing, marketing, re-selling, or distributing health care go"
    },
    {
      "type": "text",
      "section": "Relevant Financial Relationship Disclosure",
      "line": 670,
      "preview": "The following persons in control of this activity\u2019s content have relevant financial relationships:"
    },
    {
      "type": "text",
      "section": "Relevant Financial Relationship Disclosure",
      "line": 672,
      "preview": "- Phil Ayers: Fresenius Kabi, consultant and speaker"
    },
    {
      "type": "text",
      "section": "Relevant Financial Relationship Disclosure",
      "line": 673,
      "preview": "- David Evans: Fresenius Kabi, consultant and speaker; Abbott Laboratories, consultant and speaker; "
    },
    {
      "type": "text",
      "section": "Relevant Financial Relationship Disclosure",
      "line": 674,
      "preview": "- Andrew Mays: Fresenius Kabi, speaker"
    },
    {
      "type": "text",
      "section": "Relevant Financial Relationship Disclosure",
      "line": 675,
      "preview": "- Jay Mirtallo: Fresenius Kabi, consultant"
    },
    {
      "type": "text",
      "section": "Relevant Financial Relationship Disclosure",
      "line": 676,
      "preview": "- Kris Mogensen: Baxter, speaker; ThriveRx, advisory board; Pfizer, advisory board"
    },
    {
      "type": "text",
      "section": "Relevant Financial Relationship Disclosure",
      "line": 678,
      "preview": "All other persons in control of content do not have any relevant financial relationships with an ine"
    },
    {
      "type": "text",
      "section": "Relevant Financial Relationship Disclosure",
      "line": 680,
      "preview": "As required by the Standards of Integrity and Independence in Accredited Continuing Education defini"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Methods and CE Requirements",
      "line": 682
    },
    {
      "type": "text",
      "section": "Methods and CE Requirements",
      "line": 684,
      "preview": "This online activity consists of a combined total of 12 learning modules. Pharmacists and physicians"
    },
    {
      "type": "text",
      "section": "Methods and CE Requirements",
      "line": 686,
      "preview": "Participants must participate in the entire activity, complete the evaluation and all required compo"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "Important Note \u2013 ACPE 60 Day Deadline:",
      "line": 688
    },
    {
      "type": "text",
      "section": "Important Note \u2013 ACPE 60 Day Deadline:",
      "line": 690,
      "preview": "Per ACPE requirements, CPE credit must be claimed within 60 days of being earned. To verify that you"
    },
    {
      "type": "heading",
      "level": 1,
      "section": "System Technical Requirements",
      "line": 692
    },
    {
      "type": "text",
      "section": "System Technical Requirements",
      "line": 694,
      "preview": "Courses and learning activities are delivered via your Web browser and Acrobat PDF. Users should hav"
    },
    {
      "type": "text",
      "section": "System Technical Requirements",
      "line": 696,
      "preview": "View Frequently Asked Questions for more information."
    }
  ],
  "images": [
    {
      "sha_name": "a1843a3ab3082a6b.png",
      "original_ref": "img-0.jpeg",
      "page": 1,
      "relative_path": "images/a1843a3ab3082a6b.png",
      "absolute_path": "/Users/cv/Desktop/MistralOCR RAG/data/parsed/9_AcidBaseDisorders/images/a1843a3ab3082a6b.png",
      "bbox": {
        "x": 0.0,
        "y": 0.0,
        "w": 0.0,
        "h": 0.0
      },
      "caption": "",
      "hash": "a1843a3ab3082a6b"
    },
    {
      "sha_name": "2f51ff233a710ba1.png",
      "original_ref": "img-1.jpeg",
      "page": 28,
      "relative_path": "images/2f51ff233a710ba1.png",
      "absolute_path": "/Users/cv/Desktop/MistralOCR RAG/data/parsed/9_AcidBaseDisorders/images/2f51ff233a710ba1.png",
      "bbox": {
        "x": 0.0,
        "y": 0.0,
        "w": 0.0,
        "h": 0.0
      },
      "caption": "",
      "hash": "2f51ff233a710ba1"
    }
  ],
  "extraction": {
    "ocr_model": "mistral-ocr-latest",
    "request_id": "local-1754696257",
    "ts": "2025-08-08T23:37:37.370927+00:00"
  }
}